HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique

European Journal of Clinical Pharmacology

Volumn 70, Issue 3, 2014, Pages 275-278

  Borgiani, Paola ^a   Di Fusco, Davide ^a   Erba, Fulvio ^a   Marazzi, Maria C ^b   Mancinelli, Sandro ^a   Novelli, Giuseppe ^a   Palombi, Leonardo ^a   Ciccacci, Cinzia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LUMSA UNIVERSITY   (Italy)

Author keywords

HCP5 gene; Polymorphisms; PSORS1C1 gene; Stevens Johnson Syndrome (SJS); Susceptibility; Toxic epidermal necrolysis (TEN)

Indexed keywords

ALLELES; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINEAR MODELS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOZAMBIQUE; NEVIRAPINE; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME;

EID: 84894504316     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1622-5     Document Type: Article

References (12)

1. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138(8):1019-1024
2. Mittmann N, Knowles SR, Koo M, Shear NH, Rachlis A, Rourke SB (2012) Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study. Am J Clin Dermatol 13(1):49-54
3. Yip VL, Marson AG, Jorgensen AL, Pirmohamed M, Alfirevic A (2012) HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin Pharmacol Ther 92(6):757-765
4. Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N (2011) Association of HLA-B5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. BMC Med Genet 12:118
5. Carr DF, Chaponda M, Jorgensen AL, Castro EC, van Oosterhout JJ, Khoo SH, Lalloo DG, Heyderman RS, Alfirevic A, Pirmohamed M (2013) Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population. Clin Infect Dis 56(9):1330-1339
6. Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z, Japan Pharmacogenomics Data Science Consortium (2013) A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Pharmacogenomics J 13(1):60-69
7. Génin E, Schumacher M, Roujeau JC, Naldi L, Liss Y, Kazma R, Sekula P, Hovnanian A, Mockenhaupt M (2011) Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe. Orphanet J Rare Dis 6:52
8. Ciccacci C, Di Fusco D, Marazzi MC, Zimba I, Erba F, Novelli G, Palombi L, Borgiani P, Liotta G (2013) Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study. Eur J Clin Pharmacol 69(11):1909-1916
9. Excoffier L, Lischer HE (2010) Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10(3):564-567
10. Rzany B, Mockenhaupt M, Stocker U, Hamouda O, Schöpf E (1993) Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch Dermatol 129(8):1059
11. Warren KJ, Boxwell DE, Kim NY, Drolet BA (1998) Nevirapine-associated Stevens-Johnson syndrome. Lancet 351(9102):567
12. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC, EuroSCAR Study Group (2001) Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 15(14):1843-1848